TRIBULUS 625
Natural health product licensed in Canada
- Other names
- KONIG TRIBULUS 625
- Licence holder
- Provita Nutrition and Health Inc.
- NPN or DIN-HM
- 80040524
- Status
- Active licence
- Licence date
- 5 March 2013
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
Medicinal composition not provided.
Non-medicinal ingredients
Hypromellose, Cellulose microcristalline, Stéarate de magnésium, Laque d'aluminium FD&C Rouge n° 3
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Capsule | minimum: 2 Tous les jours ; maximum: 3 Tous les jours |
Uses authorised in Canada
Traditionally used in Ayurveda as Vrsya (aphrodisiac) for men. Traditionally used in Ayurveda for relief of Mutrakrcchra (difficult/painful urination).
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Effets indésirables connus
Hypersensitivity/allergy has been known to occur. If this is the case, discontinue use. Diuretic effect may occur. If this is the case, discontinue use.
- Précautions et mises en garde
If symptoms persist or worsen, discontinue use and consult a health care practitioner. If you are pregnant, consult a health care practitioner prior to use.
Source
Official Health Canada record, licence 80040524
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.